Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Nuwellis, Inc. (NUWE)

0.9999 +0.0407 (+4.24%)
As of 10:03:57 AM EDT. Market Open.
Chart Range Bar
Loading chart for NUWE
  • Previous Close 0.9592
  • Open 1.0500
  • Bid 0.7280 x 200
  • Ask 1.2900 x 200
  • Day's Range 0.9802 - 1.0600
  • 52 Week Range 0.9400 - 185.1500
  • Volume 19,617,196
  • Avg. Volume 3,000,273
  • Market Cap (intraday) 3.175M
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 2,548.3401
  • Earnings Date Nov 11, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

www.nuwellis.com

38

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 8/26/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NUWE
98.36%
S&P 500 (^GSPC)
12.30%

1-Year Return

NUWE
99.45%
S&P 500 (^GSPC)
18.89%

3-Year Return

NUWE
100.00%
S&P 500 (^GSPC)
74.49%

5-Year Return

NUWE
100.00%
S&P 500 (^GSPC)
71.98%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 2.42M
Earnings -2.42M
Profit Margin -99.92%

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-10M
-5M
0
-600.0%
-400.0%
-200.0%
0.0%

Analyst Insights

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/13/2024
Analyst Roth MKM
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 17 -> 17

Statistics

View More

Valuation Measures

Annual
As of 8/14/2026
  • Market Cap

    3.02M

  • Enterprise Value

    -695.62k

  • Trailing P/E

    0.03

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.01

  • Price/Book (mrq)

    0.18

  • Enterprise Value/Revenue

    0.00

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -125.63%

  • Return on Assets (ttm)

    -87.83%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    9.01M

  • Net Income Avi to Common (ttm)

    -11.32M

  • Diluted EPS (ttm)

    2,548.3401

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.92M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -11.44M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.9999 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: